CD38 and Burkitt lymphoma: The ability of CD38-specific hcAbs to induce complement-dependent cytotoxicity (CDC) was tested with a human multiple myeloma cell line (LP-1) and two human Burkitt's lymphoma cell lines (Daudi, CA46).